Respaire-30 Interactions
There are 220 drugs known to interact with Respaire-30 (guaifenesin/pseudoephedrine), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 21 are major, 193 are moderate, and 6 are minor.
- View all 220 medications that may interact with Respaire-30
- View Respaire-30 alcohol/food interactions (1)
- View Respaire-30 disease interactions (6)
Most frequently checked interactions
View interaction reports for Respaire-30 (guaifenesin / pseudoephedrine) and the medicines listed below.
- acetaminophen / hydrocodone
- acetaminophen / propoxyphene
- Adderall (amphetamine / dextroamphetamine)
- Allegra Allergy (fexofenadine)
- Ambien (zolpidem)
- Azithromycin Dose Pack (azithromycin)
- baclofen
- chlorpheniramine
- citalopram
- clonazepam
- doxepin
- gabapentin
- ibuprofen
- Maxalt-MLT (rizatriptan)
- Omnaris (ciclesonide nasal)
- phenobarbital
- promethazine
- Prozac (fluoxetine)
- Remeron (mirtazapine)
- Risperdal (risperidone)
- risperidone
- Sonata (zaleplon)
- tizanidine
- tramadol
- trazodone
- Valium (diazepam)
- Vistaril (hydroxyzine)
- Vyvanse (lisdexamfetamine)
- Xyzal (levocetirizine)
- Zyprexa (olanzapine)
Respaire-30 alcohol/food interactions
There is 1 alcohol/food interaction with Respaire-30 (guaifenesin / pseudoephedrine).
Respaire-30 disease interactions
There are 6 disease interactions with Respaire-30 (guaifenesin / pseudoephedrine) which include:
More about Respaire-30 (guaifenesin / pseudoephedrine)
- Respaire-30 consumer information
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.